Research & Development
Pharmaceutical R&D has never felt more like the front line.
Not only is the pipeline shrinking, but proposed changes to patent rules can limit your ability to build a portfolio, and sustain market share. As innovation stalls, generics pour into the markets you need to address.
With decades of experience in collecting and analyzing essential data, Thomson Reuters knows the industry — both the way it stands now, and the trends that will drive successful innovation in the future.
The latest information, expert analysis and current opinion on genetics, biological and translational research, including biomarkers.
Key Solution
Integrity: Scientifically-focused drug R&D database integrating biological, chemical and pharmacological data on more than 300,000 compounds.
Market and patent intelligence, API routes of synthesis, unique industry analysis and news on every stage of chemical development.
Key Solution
Integrity: Scientifically-focused drug R&D database integrating biological, chemical and pharmacological data on more than 300,000 compounds.
Knowledge and analysis to support your R&D programs and guide your pipeline decisions from portfolio evaluation to launch.
Key Solution
Integrity: Scientifically-focused drug R&D database integrating biological, chemical and pharmacological data on more than 300,000 compounds.
Thomson Innovation: Thomson Innovation enables you to make more confident IP decisions with the most trusted global patent data, scientific literature, business information integrated with powerful analytics and easy-to-use workflow tools.
Derwent World Patent Index: Get insights you would otherwise miss and make more confident decisions with Derwent World Patents Index (DWPI), the most trusted source of patent information, expertly indexed and featuring enhanced titles and comprehensive abstracts.
Essential data, regulatory intelligence and benchmarking knowledge to help you plan, populate, conduct and analyze your trials.
Key Solution
Thomson Reuters Pharma: Competitor intelligence database integrating more than 40 pharmaceutical data sources, unique abstracts, commentaries and analysis.
Feedback